About us

Rob joined OPEN Health in 2014 and is now the Group CEO. With over 30 years of experience, he has worked at both Novartis and GSK before running advertising and medical communications agencies at Publicis. He left Publicis to create and run a novel prelaunch strategic consultancy for 8 years before joining OPEN health in various roles prior to his current position. Rob is a pharmacist by training who has also obtained an MBA.

Sandy was one of the original founders of OPEN Health in 2011. Sandy is a pharmacist by profession and has over 30 years of experience in the industry. She has broad experience in pharmaceutical marketing and communications at global, European, and UK domestic levels. Prior to co-founding OPEN Health, Sandy worked in clinical development, sales, marketing, and communications at Novartis and Sanofi, and headed up European business for Huntsworth Health. As COO, Sandy’s main focus is setting and delivering the OPEN Health strategy, with a focus on maintaining the company’s unique culture, supporting strategic client partnerships, driving internal collaboration and integration, and identifying strategic partnership and acquisition opportunities.

David joined OPEN Health in 2019 as the group CFO. He is a Chartered Accountant, received training at Arthur Andersen, and has 20 years of pharmaceutical industry experience in senior finance roles. Prior to joining OPEN Health, David was Group CFO of Vernalis plc, a UK-listed pharmaceutical business that was sold to Ligand Inc. in 2018. David was also previously Group CFO of Acambis plc, a vaccine company, and Group Financial Controller of Shire plc.

Jeff joined OPEN Health in 2020 and has overall accountability for the four integrated Evidence & Access Centers of Excellence: Patient-Centered Outcomes & Patient Engagement, Real-World Evidence, Modeling & Meta-Analysis, and Strategic Market Access. Jeff is responsible for over 260 staff members globally following the merger in 2019 of Pharmerit International into the OPEN Health family, and is a member of the Global Executive Team. Previously, Jeff led the strategic HTA communications, modeling, and evidence synthesis group at Evidera/PPD after successfully leading the Global Business Development team for nearly 5 years. Jeff was formerly a Director of Primary Care in the UK NHS with local payer and service redesign responsibilities, and has been involved in healthcare and health research for 25 years. Jeff has a PhD in Medical Sciences from the University of Exeter, UK.

Angus joined OPEN Health in 2021 and is responsible for leading our people and organization strategy, including developing strong talent and leadership, effective organizations, strategic capabilities, and an engaging culture and work environment. Prior to joining OPEN Health, Angus held positions as VP, HR Clinical Development for Syneos Health and head of HR for European and international markets for ALK. Angus has more than 15 years of experience across the pharmaceutical and life science sectors, is a graduate of Heriot Watt University, and is a Fellow of the CIPD.

Allyson joined OPEN Health in 2008 and has overall accountability for IT, governance, risk, compliance, legal, and facilities. Allyson is also the Chair of OPEN Health’s Global Health and Safety Committee.

Prior to joining the OPEN Health group of companies, Allyson worked for Peloton Advantage and Compuware Corporation, where she provided guidance to management teams by understanding cross-functional views of their quantitative and qualitative data with the objective of revenue maximization and resource optimization. In 2016, Allyson was selected as one of New Jersey's 2016 "Best 50 Women in Business" by NJBIZ magazine, an award based on outstanding contributions to the state of New Jersey in one’s chosen industry and in the community. She was chosen for this award based on her career accomplishments, leadership, vision, community service, and support of the personal and professional growth of women.